Bausch Health, along with its financial and legal advisors, will continue its efforts to work on various liability management alternatives, including raising new debt financing. Our priority is to ...

SAN DIEGO - Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company specializing in virus-related cancers, has announced it will terminate its employees and begin winding down ...

FORT WORTH, Texas - PharmChem, Inc. (OTC: PCHM), known for its drug-detecting sweat patches and currently trading at $3.07 near its 52-week low, announced Monday that its Board of Directors is ...

The analysis of strategic alternatives will include an assessment of various possible scenarios, including but not limited to raising additional capital or attracting a strategic investor ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “ ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

Turnstone has engaged a financial advisor to assist in this process, and along with support from its other advisors, intends to explore potential strategic alternatives that may include, but are not ...

LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives throu ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.